MYCN and neuroblastoma: Based on age at diagnosis, MYCN amplification status, International Neuroblastoma Staging System (INSS) stage, histopathology and tumor cell ploidy, NB patients are stratified into low-, intermediate-, and high-risk groups according to the 2007 COG risk system (2, 3).